drug
DisPATCH
Preclinicalupdated 6mo agoby RootPath Genomics Inc
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(10)
- Summit’s rejection, Isomorphic’s record $5B raise, obesity and Alzheimer’s in the spotlightThe FDA declined to approve Summit Therapeutics’ Akeso-partnered ivonescimab, putting other PD-1/VEGF drug developers on notice; Isomorphic bagged a $5 billion series C, the largest in biotech hist…biospace · 9h ago
- Faith-based addiction recovery groups don’t often get federal funding. RFK Jr. wants to change thatAs RFK Jr. pushes federal support for faith-based recovery groups, medical experts express concern over access to addiction medications.stat · 1d ago
- Critical decisions that spurred these 40 Under 40 winners to successSecuring financing that allowed an exit from academia, leaving ecology and evolutionary biology for biomedical engineering and shifting from business development to entrepreneurship are among key t…biospace · 27d ago
- BioSpace 40 Under 40 winners make their mark on biopharma40 Under 40 honorees’ accomplishments include co-developing the world’s first synthetic biology programming language for mRNA and co-founding and leading a company acquired for $700 million up-fron…biospace · 1mo ago
- The FDA’s Overton era, and dispatches from ShanghaiThe Readout LOUD is going international this week with a dispatch from Shanghai, along with notes on the FDA's Overton era.stat · 1mo ago
- New federal autism committee head has financial ties to leucovorinRFK Jr. has installed John Gaitanis, a pediatric neurologist, as the new chair of the Interagency Autism Coordinating Committee, which helps the federal government decide how to allocate roughly $2…stat · 1mo ago
- Who supports policies for ‘health equity’? It depends on how you’re askingKennedy speaks at the Children's Health Defense, medical facilities under attack in Sudan, and more health news from Morning Roundsstat · 2mo ago
- STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and moreIn today's Pharmalittle newsletter, drug pricing deals, a new cancer therapy approval, and more of the latest pharma headlines.stat · 2mo ago
- STAT+: Why Schrödinger CEO Ramy Farid changed how he’s thinking about AIIn this edition of STAT's AI Prognosis: Why Schrödinger CEO Ramy Farid is rethinking AI, Recursion's neuron map, and more health AI news.stat · 3mo ago
- STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicatedIn this edition of AI Prognosis: A conversation about benchmarking leading clinical chatbots, investor view on AI in biopharma, and more.stat · 3mo ago
Data sources
last refreshed 8h ago
Found something off?
comments(0)
5-min edit window · permanent after that